Oppenheimer Maintains Outperform on NuCana, Lowers Price Target to $25
Portfolio Pulse from Benzinga Newsdesk
Oppenheimer analyst Leland Gershell maintains an Outperform rating on NuCana (NASDAQ:NCNA) but lowers the price target significantly from $150 to $25.
September 03, 2024 | 1:22 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Oppenheimer has maintained its Outperform rating on NuCana but has significantly reduced the price target from $150 to $25, indicating a reassessment of the company's valuation.
The significant reduction in the price target from $150 to $25 suggests a major reassessment of NuCana's valuation by Oppenheimer, which could negatively impact investor sentiment despite the maintained Outperform rating.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100